Application 022418
- Type
- NDA
- Sponsor
- ATHENA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | FIBRICOR | FENOFIBRIC ACID | TABLET;ORAL | 35MG | Yes | No |
| 002 | FIBRICOR | FENOFIBRIC ACID | TABLET;ORAL | 105MG | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N022418-001 | FIBRICOR | FENOFIBRIC ACID | 35MG | TABLET / ORAL | RLD | 2009-08-14 | |
| N022418-002 | FIBRICOR | FENOFIBRIC ACID | 105MG | TABLET / ORAL | RLD | 2009-08-14 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N022418-001 | 7569612 | 2027-08-20 | U-1000 | ||
| N022418-001 | 7741373 | 2027-08-20 | U-1059 | ||
| N022418-001 | 7741374 | 2027-08-20 | U-1060 | ||
| N022418-001 | 7741374 | 2027-08-20 | U-1061 | ||
| N022418-001 | 7915247 | 2027-08-20 | U-1000 | 2011-03-30 | |
| N022418-001 | 7915247 | 2027-08-20 | U-1059 | 2011-03-30 | |
| N022418-001 | 7915247 | 2027-08-20 | U-1061 | 2011-03-30 | |
| N022418-002 | 7569612 | 2027-08-20 | U-1000 | ||
| N022418-002 | 7741373 | 2027-08-20 | U-1059 | ||
| N022418-002 | 7741374 | 2027-08-20 | U-1060 | ||
| N022418-002 | 7741374 | 2027-08-20 | U-1061 | ||
| N022418-002 | 7915247 | 2027-08-20 | U-1000 | ||
| N022418-002 | 7915247 | 2027-08-20 | U-1059 | ||
| N022418-002 | 7915247 | 2027-08-20 | U-1061 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-04-04 05:41 UTC | 2022-04 | N022418-001 | FIBRICOR | 35MG | TABLET / ORAL | RLD | 2009-08-14 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | N022418-002 | FIBRICOR | 105MG | TABLET / ORAL | RLD, RS | 2009-08-14 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N022418-001 | FIBRICOR | 35MG | TABLET / ORAL | RLD | 2009-08-14 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N022418-002 | FIBRICOR | 105MG | TABLET / ORAL | RLD, RS | 2009-08-14 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | N022418-001 | FIBRICOR | 35MG | TABLET / ORAL | RLD | 2009-08-14 | bb7c543d1eb4… | |
| 2022-03-09 01:35 UTC | 2022-03 | N022418-002 | FIBRICOR | 105MG | TABLET / ORAL | RLD, RS | 2009-08-14 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N022418-001 | FIBRICOR | 35MG | TABLET / ORAL | RLD | 2009-08-14 | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | N022418-002 | FIBRICOR | 105MG | TABLET / ORAL | RLD, RS | 2009-08-14 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N022418-001 | FIBRICOR | 35MG | TABLET / ORAL | RLD | 2009-08-14 | 87673890dc5c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N022418-002 | FIBRICOR | 105MG | TABLET / ORAL | RLD, RS | 2009-08-14 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | N022418-001 | FIBRICOR | 35MG | TABLET / ORAL | RLD | 2009-08-14 | 5aa47cf7b7d7… | |
| 2021-03-12 10:30 UTC | 2021-03 | N022418-002 | FIBRICOR | 105MG | TABLET / ORAL | RLD, RS | 2009-08-14 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | N022418-001 | FIBRICOR | 35MG | TABLET / ORAL | RLD | 2009-08-14 | 8869cabd3fbd… | |
| 2020-12-22 03:56 UTC | 2020-12 | N022418-002 | FIBRICOR | 105MG | TABLET / ORAL | RLD, RS | 2009-08-14 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | N022418-001 | FIBRICOR | 35MG | TABLET / ORAL | RLD | 2009-08-14 | c0c555d07b60… | |
| 2020-11-12 02:37 UTC | 2020-11 | N022418-002 | FIBRICOR | 105MG | TABLET / ORAL | RLD, RS | 2009-08-14 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | N022418-001 | FIBRICOR | 35MG | TABLET / ORAL | RLD | 2009-08-14 | 3f01610625f2… | |
| 2019-12-14 00:12 UTC | 2019-12 | N022418-002 | FIBRICOR | 105MG | TABLET / ORAL | RLD, RS | 2009-08-14 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | N022418-001 | FIBRICOR | 35MG | TABLET / ORAL | RLD | 2009-08-14 | b00525d2431f… | |
| 2019-09-15 20:21 UTC | 2019-09 | N022418-002 | FIBRICOR | 105MG | TABLET / ORAL | RLD, RS | 2009-08-14 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | N022418-001 | FIBRICOR | 35MG | TABLET / ORAL | RLD | 2009-08-14 | ea99ee380514… | |
| 2019-07-19 19:46 UTC | 2019-07 | N022418-002 | FIBRICOR | 105MG | TABLET / ORAL | RLD, RS | 2009-08-14 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N022418-001 | FIBRICOR | 35MG | TABLET / ORAL | RLD | 2009-08-14 | 6a51e52b5d6a… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N022418-002 | FIBRICOR | 105MG | TABLET / ORAL | RLD | 2009-08-14 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N022418-001 | FIBRICOR | 35MG | TABLET / ORAL | RLD | 2009-08-14 | 1c564ffb4f44… | |
| 2024-02-18 07:12 UTC | 2024-02 | N022418-002 | FIBRICOR | 105MG | TABLET / ORAL | RLD | 2009-08-14 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N022418-001 | FIBRICOR | 35MG | TABLET / ORAL | RLD | 2009-08-14 | ea1830bbd6c7… | |
| 2023-12-20 04:57 UTC | 2023-12 | N022418-002 | FIBRICOR | 105MG | TABLET / ORAL | RLD | 2009-08-14 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N022418-001 | FIBRICOR | 35MG | TABLET / ORAL | RLD | 2009-08-14 | a72a2bbeb626… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N022418-002 | FIBRICOR | 105MG | TABLET / ORAL | RLD | 2009-08-14 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N022418-001 | FIBRICOR | 35MG | TABLET / ORAL | RLD | 2009-08-14 | 9b2671bbb829… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N022418-002 | FIBRICOR | 105MG | TABLET / ORAL | RLD | 2009-08-14 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N022418-001 | FIBRICOR | 35MG | TABLET / ORAL | RLD | 2009-08-14 | a67488948f0b… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N022418-002 | FIBRICOR | 105MG | TABLET / ORAL | RLD | 2009-08-14 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N022418-001 | FIBRICOR | 35MG | TABLET / ORAL | RLD | 2009-08-14 | 3f0d92c62455… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N022418-002 | FIBRICOR | 105MG | TABLET / ORAL | RLD | 2009-08-14 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | N022418-001 | FIBRICOR | 35MG | TABLET / ORAL | RLD | 2009-08-14 | 053a50430f4f… | |
| 2023-05-13 08:27 UTC | 2023-05 | N022418-002 | FIBRICOR | 105MG | TABLET / ORAL | RLD | 2009-08-14 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | N022418-001 | FIBRICOR | 35MG | TABLET / ORAL | RLD | 2009-08-14 | 3bdfa0b2c4d7… | |
| 2023-01-26 05:58 UTC | 2023-01 | N022418-002 | FIBRICOR | 105MG | TABLET / ORAL | RLD | 2009-08-14 | 3bdfa0b2c4d7… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | N022418-001 | 7569612 | 2027-08-20 | U-1000 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N022418-001 | 7741373 | 2027-08-20 | U-1059 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N022418-001 | 7741374 | 2027-08-20 | U-1061 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N022418-001 | 7741374 | 2027-08-20 | U-1060 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N022418-001 | 7915247 | 2027-08-20 | U-1061 | 2011-03-30 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N022418-001 | 7915247 | 2027-08-20 | U-1059 | 2011-03-30 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N022418-001 | 7915247 | 2027-08-20 | U-1000 | 2011-03-30 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N022418-002 | 7569612 | 2027-08-20 | U-1000 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N022418-002 | 7741373 | 2027-08-20 | U-1059 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N022418-002 | 7741374 | 2027-08-20 | U-1061 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N022418-002 | 7741374 | 2027-08-20 | U-1060 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N022418-002 | 7915247 | 2027-08-20 | U-1000 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N022418-002 | 7915247 | 2027-08-20 | U-1059 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N022418-002 | 7915247 | 2027-08-20 | U-1061 | d4dbc9d85df4… | ||
| 2026-10-15 13:18:30 | 2026-09 | N022418-001 | 7569612 | 2027-08-20 | U-1000 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N022418-001 | 7741373 | 2027-08-20 | U-1059 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N022418-001 | 7741374 | 2027-08-20 | U-1061 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N022418-001 | 7741374 | 2027-08-20 | U-1060 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N022418-001 | 7915247 | 2027-08-20 | U-1061 | 2011-03-30 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N022418-001 | 7915247 | 2027-08-20 | U-1059 | 2011-03-30 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N022418-001 | 7915247 | 2027-08-20 | U-1000 | 2011-03-30 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N022418-002 | 7569612 | 2027-08-20 | U-1000 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N022418-002 | 7741373 | 2027-08-20 | U-1059 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N022418-002 | 7741374 | 2027-08-20 | U-1061 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N022418-002 | 7741374 | 2027-08-20 | U-1060 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N022418-002 | 7915247 | 2027-08-20 | U-1000 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N022418-002 | 7915247 | 2027-08-20 | U-1059 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N022418-002 | 7915247 | 2027-08-20 | U-1061 | c2088c7a36db… | ||
| 2026-09-14 22:38:34 | 2026-08 | N022418-001 | 7569612 | 2027-08-20 | U-1000 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N022418-001 | 7741373 | 2027-08-20 | U-1059 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N022418-001 | 7741374 | 2027-08-20 | U-1061 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N022418-001 | 7741374 | 2027-08-20 | U-1060 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N022418-001 | 7915247 | 2027-08-20 | U-1061 | 2011-03-30 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N022418-001 | 7915247 | 2027-08-20 | U-1059 | 2011-03-30 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N022418-001 | 7915247 | 2027-08-20 | U-1000 | 2011-03-30 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N022418-002 | 7569612 | 2027-08-20 | U-1000 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N022418-002 | 7741373 | 2027-08-20 | U-1059 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N022418-002 | 7741374 | 2027-08-20 | U-1061 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N022418-002 | 7741374 | 2027-08-20 | U-1060 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N022418-002 | 7915247 | 2027-08-20 | U-1000 | 84e616aacf4f… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Fenofibric Acid | FENOFIBRIC ACID | Alembic Pharmaceuticals Inc. | 8ffcb173-095a-4550-84f2-18959ad2aab8 | 2026-03-18 | Warnings, Adverse reactions | FENOFIBRIC ACID |
| FENOFIBRIC ACID | FENOFIBRIC ACID | Leading Pharma, LLC | daa488be-f580-430c-a72c-80ac31bb3e40 | 2025-08-22 | Warnings, Adverse reactions | FENOFIBRIC ACID |
| FENOFIBRIC ACID | FENOFIBRIC ACID | Aurobindo Pharma Limited | 9ad201de-fa62-4c49-bc61-ee09b9ba434c | 2025-08-02 | Warnings, Adverse reactions | FENOFIBRIC ACID |
| Fenofibric acid | FENOFIBRIC ACID | Macleods Pharmaceuticals Limited | af225492-73b0-49bb-b32f-5399c3c3ec6d | 2025-07-03 | Warnings, Adverse reactions | FENOFIBRIC ACID |
| Fenofibric Acid | FENOFIBRIC ACID | Amneal Pharmaceuticals of New York LLC | e73404c5-e0ee-48e9-8b09-7a00d7e18e6c | 2025-06-23 | Warnings, Adverse reactions | FENOFIBRIC ACID |
| Fenofibric acid | FENOFIBRIC ACID | Lupin Pharmaceuticals, Inc. | b9a3f97c-9e31-4a5f-822f-c9d45e394493 | 2023-12-08 | Warnings, Adverse reactions | FENOFIBRIC ACID |
| Fenofibric Acid | FENOFIBRIC ACID | Alembic Pharmaceuticals Limited | c880d43a-fa8c-4f7a-a488-419bae7cc311 | 2023-01-30 | Warnings, Adverse reactions | FENOFIBRIC ACID |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 13310-101 | FIBRICOR | Fenofibric Acid | AR Scientific, Inc. | NDA | Current |
| 13310-102 | FIBRICOR | Fenofibric Acid | AR Scientific, Inc. | NDA | Current |
| 49708-101 | FIBRICOR | Fenofibric Acid | Caraco Pharma, Inc. | NDA | Current |
| 49708-102 | FIBRICOR | Fenofibric Acid | Caraco Pharma, Inc. | NDA | Current |
| 53489-677 | Fenofibric Acid | Fenofibric Acid | Mutual Pharmaceutical Company, Inc. | NDA AUTHORIZED GENERIC | Current |
| 53489-678 | Fenofibric Acid | Fenofibric Acid | Mutual Pharmaceutical Company, Inc. | NDA AUTHORIZED GENERIC | Current |
| 68134-601 | Fenofibric Acid | Fenofibric Acid | Palmetto Pharmaceuticals, Inc | NDA AUTHORIZED GENERIC | Current |
| 68134-602 | Fenofibric Acid | Fenofibric Acid | Palmetto Pharmaceuticals, Inc | NDA AUTHORIZED GENERIC | Current |
| 69916-035 | FIBRICOR | Fenofibric Acid | Tribute Pharmaceuticals US, Inc. | NDA | Current |
| 69916-105 | FIBRICOR | Fenofibric Acid | Tribute Pharmaceuticals US, Inc. | NDA | Current |
| 69973-035 | Fenofibric Acid | Fenofibric Acid | Halton Laboratories | NDA | Current |
| 69973-105 | Fenofibric Acid | Fenofibric Acid | Halton Laboratories | NDA | Current |
| 70347-035 | FIBRICOR | Fenofibric Acid | Aralez Pharmaceuticals US Inc. | NDA | Current |
| 70347-105 | FIBRICOR | Fenofibric Acid | Aralez Pharmaceuticals US Inc. | NDA | Current |
| 71511-501 | FIBRICOR | Fenofibric Acid | Athena Bioscience, LLC | NDA | Current |
| 71511-501 | FIBRICOR | Fenofibric Acid | Athena Bioscience, LLC | NDA | Current |
| 71511-501 | FIBRICOR | Fenofibric Acid | Athena Bioscience, LLC | NDA | Current |
| 71511-501 | FIBRICOR | Fenofibric Acid | Athena Bioscience, LLC | NDA | Current |
| 71511-502 | FIBRICOR | Fenofibric Acid | Athena Bioscience, LLC | NDA | Current |
| 71511-502 | FIBRICOR | Fenofibric Acid | Athena Bioscience, LLC | NDA | Current |
| 71511-502 | FIBRICOR | Fenofibric Acid | Athena Bioscience, LLC | NDA | Current |
| 71511-502 | FIBRICOR | Fenofibric Acid | Athena Bioscience, LLC | NDA | Current |
| 72834-035 | Fenofibric Acid | Fenofibric Acid | Sarras Health, LLC | NDA AUTHORIZED GENERIC | Current |
| 72834-035 | Fenofibric Acid | Fenofibric Acid | Sarras Health, LLC | NDA AUTHORIZED GENERIC | Current |
| 72834-035 | Fenofibric Acid | Fenofibric Acid | Sarras Health, LLC | NDA AUTHORIZED GENERIC | Current |
| 72834-035 | Fenofibric Acid | Fenofibric Acid | Sarras Health, LLC | NDA AUTHORIZED GENERIC | Current |
| 72834-035 | Fenofibric Acid | Fenofibric Acid | Sarras Health, LLC | NDA AUTHORIZED GENERIC | Current |
| 72834-105 | Fenofibric Acid | Fenofibric Acid | Sarras Health, LLC | NDA AUTHORIZED GENERIC | Current |
| 72834-105 | Fenofibric Acid | Fenofibric Acid | Sarras Health, LLC | NDA AUTHORIZED GENERIC | Current |
| 72834-105 | Fenofibric Acid | Fenofibric Acid | Sarras Health, LLC | NDA AUTHORIZED GENERIC | Current |
| 72834-105 | Fenofibric Acid | Fenofibric Acid | Sarras Health, LLC | NDA AUTHORIZED GENERIC | Current |
| 72834-105 | Fenofibric Acid | Fenofibric Acid | Sarras Health, LLC | NDA AUTHORIZED GENERIC | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 82511 | SUPPL | 2025-06-09 |
| 82491 | SUPPL | 2025-06-09 |
| 67714 | SUPPL | 2021-06-07 |
| 67706 | SUPPL | 2021-06-04 |
| 60181 | SUPPL | 2019-10-01 |
| 60174 | SUPPL | 2019-10-01 |
| 58759 | SUPPL | 2019-05-16 |
| 54320 | SUPPL | 2018-05-24 |
| 54281 | SUPPL | 2018-05-21 |
| 38685 | SUPPL | 2014-01-07 |
| 7362 | SUPPL | 2014-01-07 |
| 29706 | SUPPL | 2013-03-19 |
| 38684 | SUPPL | 2013-03-11 |
| 7361 | SUPPL | 2012-12-19 |
| 7360 | SUPPL | 2012-12-19 |
| 38683 | SUPPL | 2012-12-13 |
| 17566 | SUPPL | 2012-12-13 |
| 29705 | SUPPL | 2012-03-19 |
| 38682 | SUPPL | 2012-03-16 |
| 7359 | SUPPL | 2012-01-17 |
| 38681 | SUPPL | 2012-01-06 |
| 44750 | ORIG | 2010-01-05 |
| 42518 | ORIG | 2010-01-05 |
| 17565 | ORIG | 2009-10-01 |
| 7358 | ORIG | 2009-08-21 |